The Net Clinical Benefit of Rivaroxaban for Patients With Acute Coronary Syndrome
- PMID: 30384899
- DOI: 10.1016/j.jacc.2018.07.101
The Net Clinical Benefit of Rivaroxaban for Patients With Acute Coronary Syndrome
Comment on
-
Fatal or Irreversible Bleeding and Ischemic Events With Rivaroxaban in Acute Coronary Syndrome.J Am Coll Cardiol. 2018 Jul 10;72(2):129-136. doi: 10.1016/j.jacc.2018.04.055. J Am Coll Cardiol. 2018. PMID: 29976285 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
